4-[4-(4-Fluorophenyl)-5-(2-phenyl-1H-pyrrolo[2,3-b]pyridin-4-yl)-1H-imidazol-2-yl]phenol

ID: ALA2179119

PubChem CID: 136236302

Max Phase: Preclinical

Molecular Formula: C28H19FN4O

Molecular Weight: 446.49

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc4[nH]c(-c5ccccc5)cc34)[nH]2)cc1

Standard InChI:  InChI=1S/C28H19FN4O/c29-20-10-6-18(7-11-20)25-26(33-27(32-25)19-8-12-21(34)13-9-19)22-14-15-30-28-23(22)16-24(31-28)17-4-2-1-3-5-17/h1-16,34H,(H,30,31)(H,32,33)

Standard InChI Key:  HFDJAPMETZJFMI-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 39  0  0  0  0  0  0  0  0999 V2000
    4.6341  -10.0070    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4139   -9.7626    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4243   -8.9453    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6475   -8.6836    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1631   -9.3406    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1163   -8.5168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8354   -8.9073    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5310   -8.4798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5087   -7.6621    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7849   -7.2736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0923   -7.7033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3488   -9.3343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9479   -8.6209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1315   -8.6124    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7151   -9.3166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1209  -10.0307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.9360  -10.0357    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1204  -10.1680    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5363  -10.9832    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.5320  -10.1618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8237   -9.7585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8284  -11.3933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1202  -10.9844    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5124  -11.5315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8450  -12.2787    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6583  -12.1932    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.2042   -7.2330    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    5.4385  -12.9842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6202  -12.9829    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2117  -13.6897    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6203  -14.3984    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4417  -14.3958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.8466  -13.6884    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.8979   -9.3095    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  1  1  0
  6  7  2  0
  7  8  1  0
  8  9  2  0
  9 10  1  0
 10 11  2  0
 11  6  1  0
  3  6  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
  5 12  1  0
 18 23  2  0
 22 19  2  0
 19 20  1  0
 20 21  2  0
 21 18  1  0
  2 18  1  0
 22 23  1  0
 23 24  1  0
 24 25  2  0
 25 26  1  0
 26 22  1  0
  9 27  1  0
 28 29  2  0
 29 30  1  0
 30 31  2  0
 31 32  1  0
 32 33  2  0
 33 28  1  0
 25 28  1  0
 15 34  1  0
M  END

Alternative Forms

  1. Parent:

    ALA2179119

    ---

Associated Targets(Human)

MAPK11 Tchem MAP kinase p38 beta (2785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TNIK Tchem TRAF2- and NCK-interacting kinase (1174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
STK36 Tbio Serine/threonine-protein kinase 36 (297 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SRC Tclin Tyrosine-protein kinase SRC (10310 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RIPK2 Tchem Serine/threonine-protein kinase RIPK2 (1546 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAPK14 Tchem MAP kinase p38 alpha (12866 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GAK Tchem Serine/threonine-protein kinase GAK (1150 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CSNK1E Tclin Casein kinase I epsilon (1412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 446.49Molecular Weight (Monoisotopic): 446.1543AlogP: 6.80#Rotatable Bonds: 4
Polar Surface Area: 77.59Molecular Species: NEUTRALHBA: 3HBD: 3
#RO5 Violations: 1HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.64CX Basic pKa: 4.87CX LogP: 6.13CX LogD: 6.13
Aromatic Rings: 6Heavy Atoms: 34QED Weighted: 0.28Np Likeness Score: -0.61

References

1. Selig R, Goettert M, Schattel V, Schollmeyer D, Albrecht W, Laufer S..  (2012)  A frozen analogue approach to aminopyridinylimidazoles leading to novel and promising p38 MAP kinase inhibitors.,  55  (19): [PMID:22951114] [10.1021/jm300852w]
2. Juchum M, Günther M, Döring E, Sievers-Engler A, Lämmerhofer M, Laufer S..  (2017)  Trisubstituted Imidazoles with a Rigidized Hinge Binding Motif Act As Single Digit nM Inhibitors of Clinically Relevant EGFR L858R/T790M and L858R/T790M/C797S Mutants: An Example of Target Hopping.,  60  (11): [PMID:28482151] [10.1021/acs.jmedchem.7b00178]
3. Shaikh M, Shinde Y, Pawara R, Noolvi M, Surana S, Ahmad I, Patel H..  (2022)  Emerging Approaches to Overcome Acquired Drug Resistance Obstacles to Osimertinib in Non-Small-Cell Lung Cancer.,  65  (2.0): [PMID:34323489] [10.1021/acs.jmedchem.1c00876]

Source